Bayesian Capital Management, LP Deciphera Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $319,580 - $495,283	22,411 New	22,411 $346,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $40,854 - $66,759	3,300 Added 19.64%	20,100 $372,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $228,661 - $350,898	-25,100 Reduced 59.9%	16,800 $221,000
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $287,853 - $465,509	41,900 New	41,900 $388,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.